Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glucosamine is an endogenous amino monosaccharide (2-amino-2-deoxy-D-glucose) that serves as a fundamental building block for the biosynthesis of glycosaminoglycans and proteoglycans—the key components of cartilage extracellular matrix. In cartilage, glucosamine is crucial for the synthesis of hyaluronic acid, chondroitin sulfate, and keratan sulfate, thus contributing to the strength, elasticity, and lubrication of articular cartilage. Glucosamine supplementation is widely studied and used in therapies aimed at slowing cartilage breakdown and reducing pain in osteoarthritis, although clinical evidence on its efficacy is mixed. Glucosamine acts in part by supporting anabolic cartilage metabolism and exerting anti-inflammatory effects within the joint.
Supplies substrate for glycosaminoglycan and proteoglycan synthesis in chondrocytes - Inhibits inflammatory pathways in cartilage (e.g., downregulation of NF-κB, inhibition of COX-2 expression) - Reduces production of cartilage-degrading enzymes (e.g., MMPs, aggrecanases)
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glucosamine utilization in cartilage.